[2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
Fiche publication
Date publication
octobre 2002
Journal
Bulletin du cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MARTINET Yves, Dr SPAETH Dominique
Tous les auteurs :
Bréchot JM, Molina T, Theobald S, Depierre A, Lagrange JL, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A,
Lien Pubmed
Résumé
The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French cancer centers (FNCLCC), the 20 French cancer centers, and specialists from French public universities, general hospitals and private clinics. The main objective is the development of clinical practice guidelines to improve the quality of health care and the outcome of cancer patients. The methodology is based on a literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery.
Mots clés
Carcinoma, Non-Small-Cell Lung, genetics, Cyclin-Dependent Kinase Inhibitor p16, genetics, France, Gene Expression Regulation, Neoplastic, Genes, Retinoblastoma, Genes, Tumor Suppressor, Genes, erbB-2, Genes, p53, Genes, ras, Humans, Lung Neoplasms, genetics, Mutation, Oncogenes, Prognosis, Proto-Oncogene Proteins c-bcl-2, genetics
Référence
Bull Cancer. 2002 Oct;89(10):857-67